Life Sciences Newsbrief — January 2011, Issue #27

Welcome to our monthly issue of the Life Sciences Newsbrief. This publication will provide you with a snapshot of developments in the Canadian and global life sciences industry along with upcoming Canadian events and thought leadership. If you need further information, please contact any of the life sciences professionals listed.

Life Sciences in Canada

Inflection point: Canadian Life Sciences Industry Forecast Launched!
We are pleased to present our fourth Canadian Life Sciences Industry Forecast 2011, based on a survey conducted in collaboration with BIOTECanada. The online survey, conducted in August and September 2010, was completed by 100 respondents from corporate, academic, government and other organizations in the industry.

The report is designed to understand the challenges and concerns of the Canadian life sciences industry, explore new trends and communicate reoccurring themes. The information gathered and contained within this report builds on findings from previous reports and provides an overview of current industry issues and trends. We trust that you will find the information valuable for augmenting the debate on these issues.

Please visit: www.pwc.com/ca/lsforecast to download the full report.

Q4 2010: Learn about the latest M&A activities in the North American Pharma and Life Sciences Sector
The last quarter of the year saw a significant jump in M&A activity in the North American Pharma & Life Sciences industry, with 84 announced deals.

While the number of deals increased by 33% from the prior quarter and 58% from Q1 2010, disclosed deal value fell sharply to $19.5 billion from Q3's $30.1 billion, partly due to the combination of an increase in the number of "mid-market" transactions and corporate carve-outs of non-core business units or brand.

Recording still available for Life Sciences Webcast: How to Enhance Revenues from Licensing Arrangements
On November 15, 2010 , Michael Dobner, Associate Partner and Canadian Leader Licensing Management, PwC, delivered a life sciences webcast on licensing management called How to Enhance Revenues from Licensing Arrangements. Gord Jans, Partner and Canadian Pharmaceuticals and Life Sciences Leader, PwC, introduced the session.

This webcast provided a comprehensive overview of licensing management strategies that may be considered by life sciences organizations that currently license drugs at various stages of development or are considering doing so in the future. During the webcast, Michael provided details on: what licensing management is; how license agreements can help you to maximize your revenues; what you may wish to consider in drafting your licensing agreements; principles of establishing an effective compliance program in your organization; and real life examples.

To listen to the webcast recording, please click here.
To download a copy of the PwC presentation, please click here.

Please note the webcast recording will be available for replay until February 13, 2011.

If you have any questions or need more information on Licensing Management, please contact:
Michael Dobner
Associate Partner
Canadian Leader Licensing Management, PwC
Telephone: +1 416 815 5055
Email.

Thought Leadership

Q4 2010 MoneyTree Report: Learn About the Latest Venture Capital Activity
Venture capitalists invested $21.8 billion in 3,277 deals in 2010, an increase of 19 per cent in dollars and a 12 per cent rise in deals over the prior year, according to the MoneyTree Report by PricewaterhouseCoopers LLP and the National Venture Capital Association (NVCA), based on data from Thomson Reuters. The Detailed Company & VC Firm listings for Q4 2010 will be posted online in February. Visit www.pwcmoneytree.com.

Medical Technology Innovation Scorecard: The race for global leadership
This PwC publication evaluates the innovative capacity and capabilities of nine countries (Brazil, China, France, Germany, Israel, India, Japan, United Kingdom and the United States), all current or emerging leaders in medical technology in order to track global shifts in device innovation.

Top health industry issues of 2011
According to the Health Research Institute's (HRIs) annual "Top Issues" report, 2011 is a 'makeover year' with organizations reacting to and preparing for new rules, regulations and payment models resulting from health reform and market pressures. Focus in 2011 will remain on curtailing costs, addressing new patient demands and responding to health reform. This year's report identifies 6 key trends to watch for in 2011.